Feed 6733.TWO
67
BioGend Therapeutics Co., Ltd.
6733.TWO · TWO
$25.30 -1.56% (-$0.40)
1M -1.15%
Market Cap $3.4B
P/E Ratio -
Div. Yield -
ROE 11.21%
Valuation
21 /100
Expensive P/S 15.37x
P/B 4.60x
P/E N/A
Growth
85 /100
Growing Rev. growth 91.93%
Book val. growth 1.83%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 72.03%
FCF margin 29.47%
Net margin 42.86%
Quality
3 /100
Poor ROIC 12.98%
Asset turnover 0.27x
ROE 11.21%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 17.60x
Int. coverage N/A
Stability
31 /100
Unstable Beta 0.09x
Profitable years 0
Rev. volatility 119.89%
Vprašajte StockBota o 6733.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Te-Li Chen
Employees
34
Headquarters
Taipei
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report